Table of Contents Author Guidelines Submit a Manuscript
International Journal of Microbiology
Volume 2009, Article ID 513874, 8 pages
http://dx.doi.org/10.1155/2009/513874
Research Article

Extended Spectrum -Lactamases among Gram-negative Bacterial Isolates from Clinical Specimens in Three Major Hospitals in Northern Jordan

Department of Medical laboratory Sciences, Faculty of Applied Medical Sciences, Jordan University of Science and Technology, P.O. Box 3030 Irbid 22110, Jordan

Received 21 May 2009; Accepted 25 July 2009

Academic Editor: William M. Shafer

Copyright © 2009 Raymond G. Batchoun et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Bonnet, C. De Champs, D. Sirot, C. Chanal, R. Labia, and J. Sirot, “Diversity of TEM mutants in Proteus mirabilis,” Antimicrobial Agents and Chemotherapy, vol. 43, no. 11, pp. 2671–2677, 1999. View at Google Scholar
  2. G. Arlet, G. Brami, D. Decrere et al., “Molecular characterization by PCR-restriction fragment length polymorphism of TEM ß-lactamases,” FEMS Microbiology Letters, vol. 134, pp. 1498–1500, 1995. View at Google Scholar
  3. J. Blazquez, M. I. Morosini, M.-C. Negri, and F. Baquero, “Selection of naturally occurring extended-spectrum TEM β-lactamase variants by fluctuating β-lactam pressure,” Antimicrobial Agents and Chemotherapy, vol. 44, no. 8, pp. 2182–2184, 2000. View at Publisher · View at Google Scholar
  4. J. Walther-Rasmussen and N. Høiby, “Plasmid-borne AmpC β-lactamases,” Canadian Journal of Microbiology, vol. 48, no. 6, pp. 479–493, 2002. View at Publisher · View at Google Scholar
  5. G. Arlet and A. Philippon, “Construction by polymerase chain reaction and intragenic DNA probes for three main types of transferable β-lactamases (TEM, SHV, CARB),” FEMS Microbiology Letters, vol. 82, pp. 19–26, 1991. View at Google Scholar
  6. A. Bauernfeind, I. Stemplinger, R. Jungwirth, S. Ernst, and J. M. Casellas, “Sequences of β-Lactamase genes encoding CTX-M-1 (MEN-1) and CTX-M-2 and relationship of their amino acid sequences with those of other β-lactamases,” Antimicrobial Agents and Chemotherapy, vol. 40, pp. 509–513, 1996. View at Google Scholar
  7. W. -L. Yu, Y. -C. Chuang, and J. Walther-Rasmussen, “Extended-spectrum beta-lactamases in Taiwan: epidemiology, detection, treatment and infection control,” Journal of Microbiology, Immunology and Infection, vol. 39, no. 4, pp. 264–277, 2006. View at Google Scholar
  8. S. H. Choi, J. E. Lee, S. J. Park et al., “Prevalence, microbiology, and clinical characteristics of extended-spectrum ß-lactamase-producing Enterobacter spp., Serratia marcescens, Citrobacter freundii, and Morganella morganii in Korea,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 26, no. 8, pp. 557–561, 2007. View at Publisher · View at Google Scholar
  9. D. Ivanova, R. Markovska, N. Hadjieva, I. Schneider, I. Mitov, and A. Bauernfeind, “Extended-spectrum β-lactamase-producing Serratia marcescens outbreak in a Bulgarian hospital,” Journal of Hospital Infection, vol. 70, no. 1, pp. 60–65, 2008. View at Google Scholar
  10. R. Bonnet, J. L. M. Sampaio, C. Chanal et al., “A novel class A extended-spectrum ß-lactamase (BES-1) in Serratia marcescens isolated in Brazil,” Antimicrobial Agents and Chemotherapy, vol. 44, no. 11, pp. 3061–3068, 2000. View at Publisher · View at Google Scholar
  11. J. J. Jean, P. R. Hsueh, W. S. Lee et al., “Nationwide surveillance of antimicrobial resistance among Enterobacteriaceae in intensive care units in Taiwan,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 28, no. 2, pp. 215–220, 2009. View at Publisher · View at Google Scholar
  12. J. Färber, K. A. Moder, F. Layer, I. Tammer, W. König, and B. König, “Extended-spectrum beta-lactamase detection with different panels for automated susceptibility testing and with a chromogenic medium,” Journal of Clinical Microbiology, vol. 46, no. 11, pp. 3721–3727, 2008. View at Publisher · View at Google Scholar
  13. K. Bush, G. A. Jacoby, and A. A. Medeiros, “A functional classification scheme for β-lactamases and its correlation with molecular structure,” Antimicrobial Agents and Chemotherapy, vol. 39, no. 6, pp. 1211–1233, 1995. View at Google Scholar
  14. F. H. M'Zali, A. Chanawong, K. G. Kerr, D. Birkenhead, and P. M. Hawkey, “Detection of extended-spectrum β-lactamases in members of the family Enterobacteriaceae: comparison of the MAST DD test, the double disk and the Etest ESBL,” Antimicrobial Agents and Chemotherapy, vol. 45, pp. 881–885, 2000. View at Google Scholar
  15. R. A. Bonomo, S. A. Rudin, and D. M. Shlaes, “Tazobactam is a potent inactivator of selected inhibitor-resistant class A β-lactamases,” FEMS Microbiology Letters, vol. 148, no. 1, pp. 59–62, 1997. View at Publisher · View at Google Scholar
  16. P. A. Bradford, Y. Yang, D. Sahm, I. Grope, D. Gardovska, and G. Storch, “CTX-M-5, a novel cefotaxime-hydrolyzing β-Lactamase from an out-break of Salmonella typhimurium in Latvia,” Antimicrobial Agents and Chemotherapy, vol. 42, pp. 1980–1894, 1998. View at Google Scholar
  17. C. Branger, A. L. Lesimple, B. Bruneau, P. Berry, and N. Lambert-Zechovsky, “Long-term investigation of the clonal dissemination of Klebsiella pneumoniae isolates producing extended-spectrum β-lactamases in a university hospital,” Journal of Medical Microbiology, vol. 47, no. 3, pp. 201–209, 1998. View at Publisher · View at Google Scholar
  18. P. L. Ho, D. N. C. Tsang, T. L. Que, M. Ho, and K. Y. Yuen, “Comparison of screening methods for detection of extended-spectrum β-lactamases and their prevalence among Escherichia coli and Klebsiella species in Hong Kong,” APMIS, vol. 108, no. 3, pp. 237–240, 2000. View at Publisher · View at Google Scholar
  19. H. Pai, S. Lyu, J. H. Lee et al., “Survey of extended-spectrum β-lactamases in clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence of TEM-52 in Korea,” Journal of Clinical Microbiology, vol. 37, no. 6, pp. 1758–1763, 1999. View at Google Scholar
  20. T. Yagi, H. Kruokawa, N. Shibata, K. Shibayama, and Y. Arakawa, “A preliminary survey of extended-spectrum β-lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Japan,” FEMS Microbiology Letters, vol. 184, pp. 53–56, 2000. View at Google Scholar
  21. J. J. Yan, S. M. Wu, S. H. Tsai, J. J. Wu, and I. J. Su, “Prevalence of SHV-12 among clinical isolates of Klebsiella pneumoniae producing extended-spectrum β-lactamases and identification of a novel AmpC enzyme (CMY-8) in southern Taiwan,” Antimicrobial Agents and Chemotherapy, vol. 44, pp. 1438–1442, 2000. View at Publisher · View at Google Scholar
  22. J. K. Rasheed, C. Jay, B. Metchock et al., “Evolution of extended-spectrum ß-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia,” Antimicrobial Agents and Chemotherapy, vol. 41, pp. 647–653, 1997. View at Google Scholar
  23. E. W. Koneman, S. D. Allen, W. M. Janda, P. C. Schreckenberger, and W. C. winn, Color Atlas and Textbook of Diagnostic Microbiology, JB Lippincott, Philadelphia, Pa, USA, 4th edition, 1992.
  24. P. R. Murray, E. J. Baron, M. A. Pfaller et al., Eds., Manual of Clinical Microbiology, American Society for Microbiology, Washington, DC, USA, 7th edition, 1999.
  25. E. J. Baron and S. M. Finegold, “Methods for testing antimicrobial effectiveness,” in Baily& Scott's Diagnostic Microbiology, pp. 171–194, The C.V. Mosby Company, St. Louis, Mo, USA, 1990. View at Google Scholar
  26. D. G. Evans, D. J. Evans, and H. L. DuPont, “Virulence factors of Enterotoxigenic Escherichia coli,” The Journal of Infectious Diseases, vol. 136, pp. S118–S123, 1977. View at Google Scholar
  27. National Committee for Clinical Laboratory Standards, “Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically,” Approved standard M7–A5 and informational supplement M100–S10, National Committee for Clinical Laboratory Standards, Wayne, Pa, USA, 2000.
  28. V. Jarlier, M. H. Nicolas, G. Fournier, and A. Philippon, “Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns,” Reviews of Infectious Diseases, vol. 10, no. 4, pp. 867–878, 1988. View at Google Scholar
  29. M. T. Youssef, H. I. Malkawi, A. A. Shurman, and A. O. Andremont, “Molecular typing of multiresistant Klebsiella pneumoniae isolated from children from northern Jordan,” Journal of Tropical Pediatrics, vol. 45, no. 5, pp. 271–277, 1999. View at Publisher · View at Google Scholar
  30. A. A. Shehabia, A. Mahafzah, I. Baadran, F. A. Qadar, and N. Dajani, “High incidence of Klebsiella pneumoniae clinical isolates to extended-spectrum β-lactam drugs in intensive care units,” Diagnostic Microbiology and Infectious Disease, vol. 36, no. 1, pp. 53–56, 2000. View at Publisher · View at Google Scholar
  31. P. A. Bradford, “Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat,” Clinical Microbiology Reviews, vol. 14, no. 4, pp. 933–951, 2001. View at Publisher · View at Google Scholar
  32. T. Spanu, F. Luzzaro, M. Perilli et al., “Occurrence of extended-spectrum ß-lactamases in members of the family Enterobacteriaceae in Italy: implications for resistance to ß-lactams and other antimicrobial drugs,” Antimicrobial Agents and Chemotherapy, vol. 46, no. 1, pp. 196–202, 2002. View at Publisher · View at Google Scholar
  33. H. Wang, S. Kelkar, W. Wu, M. Chen, and J. P. Quinn, “Clinical isolates of Enterobacteriaceae producing extended-spectrum β-lactamases: prevalence of CTX-M-3 at a hospital in China,” Antimicrobial Agents and Chemotherapy, vol. 47, no. 2, pp. 790–793, 2003. View at Publisher · View at Google Scholar
  34. A. A. Kader and K. Angamuthu, “Extended-spectrum β-lactamases in urinary isolates of Escherichia coli, Klebsiella pneumoniae and other gram-negative bacteria in a hospital in Eastern Province, Saudi Arabia,” Saudi Medical Journal, vol. 26, no. 6, pp. 956–959, 2005. View at Google Scholar
  35. E. M. Mokaddas, A. A. Abdulla, S. Shati, and V. O. Rotimi, “The technical aspects and clinical significance of detecting extended-spectrum β-lactamase-producing Enterobacteriaceae at a tertiary-care hospital in Kuwait,” Journal of Chemotherapy, vol. 20, no. 4, pp. 445–451, 2008. View at Google Scholar